Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nagaaki Katoh

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Internal Medicine (Tokyo, Japan)|March 4, 2014
Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptomsMasayuki Matsuda, Nagaaki Katoh, Shu-ichi Ikeda
European Heart Journal. Case Reports|June 14, 2024
Coexistence of variant-type transthyretin and immunoglobulin light-chain amyloidosis: a case reportYuko Eda, Shunsuke Ishii, Suzuho Onagi, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 22, 2025
[A case of POEMS syndrome presenting craniocervical vascular stenosis]Minori Sawada, Gaku Okumura, Ken Takasone, et al.
Internal Medicine (Tokyo, Japan)|November 8, 2021
Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated VasculopathyYusuke Takahashi, Yusuke Mochizuki, Katsuya Nakamura, et al.
Rinsho Shinkeigaku = Clinical Neurology|August 23, 2007
[A clinically diagnosed lymphocytic hypophysitis presenting as recurrent meningitis]Nagaaki Katoh, Kazuko Machida, Syunichi Satoh, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2014
Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after high-dose melphalan therapy with stem cell transplantationNagaaki Katoh, Akira Matsushima, Masahiro Kurozumi, et al.
Internal Medicine (Tokyo, Japan)|February 2, 2010
Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathyNagaaki Katoh, Masayuki Matsuda, Wataru Ishii, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2016
Liver Transplantation Is a Potential Treatment Option for Systemic Light Chain Amyloidosis Patients with Dominant Hepatic Involvement: A Case Report and Analytical Review of the LiteratureAkihiro Ueno, Nagaaki Katoh, Osamu Aramaki, et al.
Histopathology|April 17, 2018
Usefulness of gastroduodenal biopsy in the differential diagnosis of systemic AH amyloidosis from systemic AL amyloidosisShojiro Ichimata, Mikiko Kobayashi, Hisashi Shimojo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2017
Visualization of multiple organ amyloid involvement in systemic amyloidosis using <sup>11</sup>C-PiB PET imagingNaoki Ezawa, Nagaaki Katoh, Kazuhiro Oguchi, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Internal Medicine (Tokyo, Japan)|March 4, 2014
Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptomsMasayuki Matsuda, Nagaaki Katoh, Shu-ichi Ikeda
European Heart Journal. Case Reports|June 14, 2024
Coexistence of variant-type transthyretin and immunoglobulin light-chain amyloidosis: a case reportYuko Eda, Shunsuke Ishii, Suzuho Onagi, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 22, 2025
[A case of POEMS syndrome presenting craniocervical vascular stenosis]Minori Sawada, Gaku Okumura, Ken Takasone, et al.
Internal Medicine (Tokyo, Japan)|November 8, 2021
Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated VasculopathyYusuke Takahashi, Yusuke Mochizuki, Katsuya Nakamura, et al.
Rinsho Shinkeigaku = Clinical Neurology|August 23, 2007
[A clinically diagnosed lymphocytic hypophysitis presenting as recurrent meningitis]Nagaaki Katoh, Kazuko Machida, Syunichi Satoh, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2014
Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after high-dose melphalan therapy with stem cell transplantationNagaaki Katoh, Akira Matsushima, Masahiro Kurozumi, et al.
Internal Medicine (Tokyo, Japan)|February 2, 2010
Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathyNagaaki Katoh, Masayuki Matsuda, Wataru Ishii, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2016
Liver Transplantation Is a Potential Treatment Option for Systemic Light Chain Amyloidosis Patients with Dominant Hepatic Involvement: A Case Report and Analytical Review of the LiteratureAkihiro Ueno, Nagaaki Katoh, Osamu Aramaki, et al.
Histopathology|April 17, 2018
Usefulness of gastroduodenal biopsy in the differential diagnosis of systemic AH amyloidosis from systemic AL amyloidosisShojiro Ichimata, Mikiko Kobayashi, Hisashi Shimojo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2017
Visualization of multiple organ amyloid involvement in systemic amyloidosis using <sup>11</sup>C-PiB PET imagingNaoki Ezawa, Nagaaki Katoh, Kazuhiro Oguchi, et al.
Pageof 7